» Articles » PMID: 38510857

Clinical Performance of the Reverse Transcription-Loop-Mediated Isothermal Amplification Assay for the Diagnosis of COVID-19 in a Thai Community Hospital at the Thailand-Myanmar Border

Overview
Journal Cureus
Date 2024 Mar 21
PMID 38510857
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Coronavirus disease 2019 (COVID-19) continues to be a global health threat and is a public health issue in Thailand and other countries. The extensive cross-border between Thailand and Myanmar is considered to be at a potentially high risk for COVID-19 distribution in this region. In this instance, simple and cost-effective tests for rapid and early detection of COVID-19 would be useful for effective patient management and control of the disease.

Methods: This study was conducted at Mae Sot Hospital on the border of Thailand-Myanmar to evaluate the diagnostic performance of a simple colorimetric reverse transcription-loop-mediated isothermal amplification (RT-LAMP) assay developed recently for the rapid detection of SARS-CoV-2. Nasopharyngeal specimens were routinely collected and processed through automated nucleic acid extraction followed by real-time reverse transcription-polymerase chain reaction (rRT-PCR) using the Molaccu COVID-19 Detection Kit. The RT-LAMP assay was further performed on remnant RNA samples, and the visual results were compared to those of rRT-PCR as a reference.

Results: Of the 727 samples tested, the RT-LAMP assay could detect 322 out of 374 samples positive for SARS-CoV-2 by rRT-PCR with 100% (n = 353/353) negative agreement. The comparative analysis demonstrated the overall accuracy, sensitivity, specificity, positive predictive value, and negative predictive value of the RT-LAMP at 92.85% (n = 675/727, 95% CI: 90.73-94.61), 86.10% (n = 322/374, 95% CI: 82.17-89.44), 100% (n = 353/353, 95% CI: 98.96-100), 100% (n = 322/322, 95% CI: 98.86-100), and 87.16% (n = 353/405, 95% CI: 84.06-89.73), respectively.

Conclusion: This RT-LAMP assay showed good diagnostic performance in the hospital setting. It can increase laboratory capacity for rapid SARS-CoV-2 testing and has the potential for use as an alternative or a backup assay at the point of need, especially where alternatives are unavailable for any reason, such as a decline in COVID-19 cases.

References
1.
Li Y, Cao X, Luo X, Xie T, Liu W, Xie S . Evaluation of RT-LAMP Assay for Rapid Detection of SARS-CoV-2. Lab Med. 2022; 54(1):56-64. PMC: 9384514. DOI: 10.1093/labmed/lmac030. View

2.
Rivas-Macho A, Sorarrain A, Marimon J, Goni-de-Cerio F, Olabarria G . Extraction-Free Colorimetric RT-LAMP Detection of SARS-CoV-2 in Saliva. Diagnostics (Basel). 2023; 13(14). PMC: 10377860. DOI: 10.3390/diagnostics13142344. View

3.
Al-Omari M, Qaqish A, Omeish H, Najadat A, Mahasneh F, Al-Tamimi M . Review of current in vitro COVID-19 diagnostics methods. J Infect Dev Ctries. 2022; 16(9):1376-1384. DOI: 10.3855/jidc.16378. View

4.
Bwire G, Majigo M, Njiro B, Mawazo A . Detection profile of SARS-CoV-2 using RT-PCR in different types of clinical specimens: A systematic review and meta-analysis. J Med Virol. 2020; 93(2):719-725. PMC: 7404904. DOI: 10.1002/jmv.26349. View

5.
Klayut W, Wongchai T, Chuenchom N, Bhakdeenuan P, Bunchoo S, Srisungngam S . An alternative colorimetric RT-LAMP assay for the rapid detection of SARS-CoV-2: development and validation in Thailand. J Infect Dev Ctries. 2024; 18(8):1196-1203. DOI: 10.3855/jidc.19442. View